News

Treatment for advanced ovarian carcinoma is typically based on the combination of surgery and chemotherapy. The objective of surgical intervention in patients suffering from advanced disease is to

About 76 individuals with T1D, younger than 30 years of age and with HbA1c levels greater than 9.0%, are expected to be randomly assigned to receive either placebo

A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. "These patent allowances are a critical component

As previously announced, Translational Drug Development, LLC (TD2) will conduct the study. Ascites fluid accumulates in the abdomen and is usually associated with the development of advanced pancreatic

Research will be conducted in collaboration with Dr. Zeljko Vujaskovic, Director of the Division of Translational Radiation Sciences at the University of Maryland School of Medicine. Prostate cancer

The research funded by this award will be conducted in collaboration with the University of British Columbia, the Vancouver Prostate Centre and the B.C. Cancer Agency. This funding

Under the deal, the company expects that the ‘contract manufacturer’ will be able to offer sufficient manufacturing capacity at cGMP production facilities to allow commercialization of its treatment

These patients are currently being treated by commercially-available Factor VIIa, with estimated 2013 worldwide sales of $1.7 billion. Factor VIIa-CTP already obtained orphan status in the U.S. earlier

Fluphenazine decanoate injection is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics). Fluphenazine decanoate injection